Understanding and Managing Postural Orthostatic Tachycardia Syndrome
U.S. Pharm.
; 47:HS-1-HS-7, 2022.
Article
in English
| EMBASE | ID: covidwho-1812784
ABSTRACT
Postural orthostatic tachycardia syndrome (POTS) is a disorder of the autonomic nervous system that is often misunderstood and is typically seen in younger women. Emerging data suggest an association between coronavirus disease 2019 and POTS. Given the rise in POTS cases, it is imperative that clinicians and other healthcare professionals better understand this condition. Although several nonpharmacologic and pharmacologic treatments exist for patients with POTS, none are currently FDA-approved. As therapeutics experts and the most accessible members of the healthcare team, pharmacists play a pivotal role in optimizing treatment outcomes by directing patients to further evaluate symptoms and in proposing therapeutics to other healthcare professionals.
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
U.S. Pharm.
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS